MedTrace Logo

Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy Subjects

NCT05147727 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2022-12-23

No results posted yet for this study

Summary

An open-label, fixed-sequence, drug-drug interaction study to evaluate the effects of fluconazole on the pharmacokinetics and safety of famitinib in healthy subjects.

Conditions

  • Tumor

Interventions

DRUG

Fluconazole、Famitinib

Fluconazole, once daily on Days 12 to 24; Famitinib, once daily on Days 1 and 15

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-14
Primary Completion
2022-05-02
Completion
2022-05-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05147727 on ClinicalTrials.gov